Myriad Genetics
MYGN
MYGN
262 hedge funds and large institutions have $2.62B invested in Myriad Genetics in 2019 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 88 increasing their positions, 82 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less funds holding
Funds holding: 264 → 262 (-2)
2% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 44
60% less call options, than puts
Call options by funds: $21.9M | Put options by funds: $54.7M
Holders
262
Holding in Top 10
3
Calls
$21.9M
Puts
$54.7M
Top Buyers
| 1 | +$50.2M | |
| 2 | +$31.2M | |
| 3 | +$27.4M | |
| 4 |
SCM
SG Capital Management
Chicago,
Illinois
|
+$20.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$11.9M |
Top Sellers
| 1 | -$21.7M | |
| 2 | -$16.8M | |
| 3 | -$11.8M | |
| 4 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
-$11.6M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$11M |